OMB control number
Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads
OMB 0910-0861 · HHS/FDA.
OMB 0910-0861
This information collection request collects information from an adult sample of individuals who self-identify as having rheumatoid arthritis or overactive bladder regarding their perceptions of the important safety information and brief summary in direct-to-consumer prescription drug print advertising. Additionally, we will collect eye-tracking data to observe participants’ gaze maps while reading the information. Using an in-person interview methodology, we plan to conduct two 60-minute pilots with a total of 40 adults and two 60-minute studies with a total of 400 adults.
The latest form for Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads expires 2020-09-30 and is listed under ICR 201907-0910-021.
Latest Forms, Documents, and Supporting Material
| Document | Type |
|---|---|
 Justification Memorandum for 83-C change request 0910_0861.doc | Justification for No Material/Nonsubstantive Change |
 Supporting Statement PART B Risk Info and Amount Location 2018.docx | Supporting Statement B |
| Supporting Statement PART A RAAL 2018.docx | Supporting Statement A |
 Completes, Study 2 |
Other-Survey |
| Completes, Study 1 |
Other-Survey |
| Completes, Pilot |
Other-Survey |
| Study 2 Screener |
Other-Screener |
| Study 1 Screener |
Other-Screener |
| Pilot Screener |
Other-Screener |
All Historical Document Collections
| Reference | Filing | Received | Concluded | Action |
|---|---|---|---|---|
| 201907-0910-021 | No material or nonsubstantive change to a currently approved collection | 2019-07-24 | Approved with change | |
| 201807-0910-005 | New collection (Request for a new OMB Control Number) | 2018-08-15 | Approved with change |
OMB Details
Pilot Screener
Federal Enterprise Architecture: Health - Consumer Health and Safety